GX EG3 L (Leukeran 2 mg)
Generic Name: chlorambucil
Pill imprint GX EG3 L has been identified as Leukeran 2 mg.
Leukeran is used in the treatment of chronic lymphocytic leukemia; hodgkin's lymphoma; lymphoma; cancer and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Leukeran 2 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- chlorambucil
- Imprint:
- GX EG3 L
- Strength:
- 2 mg
- Color:
- Orange
- Size:
- 7.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Alkylating agents
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- GSK Pharm
- National Drug Code (NDC):
- 00173-0635
- Inactive Ingredients:
- silicon dioxide
hypromelloses
lactose anhydrous
polyethylene glycol
microcrystalline cellulose
ferric oxide red
stearic acid
titanium dioxide
ferric oxide yellow
More about Leukeran (chlorambucil)
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
